Infrastructure for healthcare personalization

Blockchain, big data, genetics and transparency are together changing how the healthcare market works. All healthcare will become personalized in the future. We are creating this future now.

How data helps personalize healthcare
scheme scheme
scheme-2 scheme-2
bin
Pharma

Per year is the average
expenditure on finding
patients in the USA

People
Most of them do not have an access
to personal treatments and have no
motivation sharing genetic and
clinical information
Small genetic companies
Trying to monetize the database
somewhere in future

How it works

We are creating an infrastructure for the combined access to a multitude of genetic and medical databases for the needs of research and clinical trials, without using directly databases merging. Cryptography and blockchain provide reliability and transparency.

All transactions history is kept in blockchain ledger and transparent to all participants:
  1. The pharmaceutical company sends a request with search criteria for genotype and phenotype.
  2. Data providers announce the amount of data that satisfy this request.
  3. Pharma offers a price.
  4. Data providers confirm the consent to sell.
  5. If a price-matched data request appears on the blockchain, GenX initiates the deal process.

Benefits

Pharma companies and Research institutions

Use data for R&D

Obtaning channel of comunication with potential clients and contributirs to R&D

Gain access to data of a variety of people belonging to varios groups

Genetics companies, clinics and biobanks

Make additional profit by providing pharma companies with access to collected data

Use of consensus mechanism to provide better treatment and data analysis

Provide a better service to their clients

Individualis

Obtains more precise and complete assessment

Offered personalized medicines by Pharma

Contributing data for good of humanity or rewards

Team

  • Kirill Petrenko

    CEO and co-founder

    Co-founder MaxyGen
    (genetic device company)
    Co-founder Genotek (successful
    genetic test analysis company)
    Startup accelerators:
    – StartUp Sauna (SV, USA),
    – StarTau (Tel Aviv, Israel)
    MSU, Ms in Math

  • Konstantin Stiskin

    Creator and co-founder

    Genotek board member
    Venture Partner at Target Global,
    more than 20 deals in other VCs
    and PEs
    More than 40 deals and 10 exits
    Vast experience in VC and as
    business-angel, including:
    – Runa Capital
    – Phenomen Ventures
    – FinSight Venture funds
    HSE and Hult BS

  • Ilya Sachkov

    Partner (cybersecurity
    and personal data)

    Founder of the leading Cyber
    security company Group IB
    Member of cybercrime expert
    committees in the Council of
    Europe and the OSCE

  • Alena Soboleva

    Advisor (pharma relations)

    Ex-founder and Executive Director
    at Skolkovo Health Economics and
    Management Centre Professional
    fundraiser with a solid experience
    in working with pharma companies
    and medical devices producers
    MSU, MS in math

Be part of an individual healthcare system